Acute coronary syndromes
KEYWORDS: people, coronary, acute, pci, risk, acute coronary, therapy, recommendations, committee, evidence, angina, unstable, nstemi, unstable angina, offer

with acute STEMI who present more than 12 hours after the onset of symptoms and who have cardiogenic shock or go on to develop it. [2013] 1.1.10 Consider radial (in preference to femoral) arterial access for people undergoing coronary angiography (with follow-on primary PCI if indicated). [2013] Dual antiplatelet therapy for people with acute STEMI having Acute coronary syndromes (NG185) primary PCI 1.1.11 For people with acute STEMI who are having primary PCI, offer: • prasugrel, as part of dual antiplatelet therapy with aspirin, if they are not already taking an oral anticoagulant (for people aged 75 and over, think about whether the person's risk of bleeding with prasugrel outweighs its effectiveness, in which case offer ticagrelor or clopidogrel as alternatives) • clopidogrel, as part of dual antiplatelet therapy with aspirin, if they are already taking an oral anticoagulant. [2020] Prasugrel and ticagrelor are recommended as options in NICE technology appraisal guidance for people with acute STEMI having primary PCI. For full details, see the guidance on: • prasugrel (TA317, 2014) • ticagrelor (TA236, 2011). For a short explanation of why the committee made the 2020 recommendation and how it might affect practice, see the rationale and impact section on
